Home›Companies›Biotech & Pharma›Topo Therapeutics

Topo Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Dec 31, 2024·Suggest an edit

About Topo Therapeutics

Topo Therapeutics is a private company based in Cambridge, Massachusetts, incorporated in 2024 in Delaware. It has reported $10,555,558 raised in one offering on Form D since December 2024. Its chief executive is Madgalene Moran.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 17, 2024Dec 30, 2024amended Dec 31, 2024$10,555,558of $95.0M target4$2.6MEquityRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Topo Therapeutics's Form D filed Dec 31, 2024.

BB
Bruce Bean
Director
HT
Hui Tian
Executive officer and director
MM
Madgalene Moran
Chief Executive Officer and director
KK

Sources

  1. SECTopo Therapeutics, Inc. Form D, filed Dec 30, 2024
  2. SECTopo Therapeutics, Inc. filing history